Search Results - "vaborbactam" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Vyzkoušejte nový nástroj s podporou AI Summon Research Assistant BETA

Cover Image

Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

by Zhanel, George G., Lawrence, Courtney K., Adam, Heather, Schweizer, Frank, Zelenitsky, Sheryl, Zhanel, Michael, Lagacé-Wiens, Philippe R. S., Walkty, Andrew, Denisuik, Andrew, Golden, Alyssa, Gin, Alfred S., Hoban, Daryl J., Lynch, Joseph P., Karlowsky, James A.
Published in Drugs (New York, N.Y.) (01.01.2018)

Get full text

Journal Article

Cover Image

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the β-Lactamase Inhibitor Vaborbactam (RPX7009) in Healthy Adult Subjects

by Griffith, David C., Loutit, Jeffery S., Morgan, Elizabeth E., Durso, Stephanie, Dudley, Michael N.
Published in Antimicrobial agents and chemotherapy (01.10.2016)

Get full text

Journal Article

Cover Image

Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment

by Rubino, Christopher M., Bhavnani, Sujata M., Loutit, Jeffery S., Lohse, Brooke, Dudley, Michael N., Griffith, David C.
Published in Antimicrobial agents and chemotherapy (01.03.2018)

Get full text

Journal Article

Cover Image

Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected Patients

by Trang, M., Griffith, D. C., Bhavnani, S. M., Loutit, J. S., Dudley, M. N., Ambrose, P. G., Rubino, C. M.
Published in Antimicrobial agents and chemotherapy (17.08.2021)

Get full text

Journal Article

Cover Image

Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram‐negative bacterial infections

by Fornari, Chiara, Arrieta, Antonio, Bradley, John S., Tout, Mira, Magalhaes, Paulo, Auriol, Faten Koraichi, Borella, Elisa, Piana, Chiara, Della Pasqua, Oscar, Vallespir, Bartomeu Piza, Mazzei, Paolo, Bokesch, Paula M., Hoover, Randall, Capriati, Angela, Habboubi, Nassir
Published in British journal of clinical pharmacology (01.10.2024)

Get full text

Journal Article

Cover Image

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Vaborbactam and Meropenem Alone and in Combination following Single and Multiple Doses in Healthy Adult Subjects

by Rubino, Christopher M., Bhavnani, Sujata M., Loutit, Jeffery S., Morgan, Elizabeth E., White, Dan, Dudley, Michael N., Griffith, David C.
Published in Antimicrobial agents and chemotherapy (01.04.2018)

Get full text

Journal Article

Cover Image

Determination of MIC and disk diffusion quality control guidelines for meropenem–vaborbactam, a novel carbapenem/boronic acid β-lactamase inhibitor combination

by Munson, Erik, Huband, Michael D., Castanheira, Mariana, Fedler, Kelley A., Flamm, Robert K.
Published in Diagnostic microbiology and infectious disease (01.04.2018)

Get full text

Journal Article

Cover Image

Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study

by Marino, Andrea, Maraolo, Alberto Enrico, Mazzitelli, Maria, Oliva, Alessandra, Geremia, Nicholas, De Vito, Andrea, Gullotta, Chiara, Scaglione, Vincenzo, Vania, Eleonora, Lo Menzo, Sara, Navalesi, Paolo, Volpicelli, Lorenzo, Fiori, Andrea, Prestifilippo, Pamela, Cattelan, Annamaria, Mastroianni, Claudio Maria, Madeddu, Giordano, Cacopardo, Bruno, Nunnari, Giuseppe
Published in Infection (16.07.2025)

Get full text

Journal Article

Cover Image

In vitro susceptibility of carbapenem resistant Enterobacterales to meropenem-vaborbactam and ceftazidime-avibactam at a single academic medical centre

by Adams, Jenna, Santarossa, Maressa, Harrington, Amanda, Bauer, Michael, Wozniak, Amy, Labuszewski, Laurie, Albarillo, Fritzie S.
Published in Infectious diseases (London, England) (03.04.2023)

Get full text

Journal Article

Cover Image

An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam

by Wenzler, Eric, Scoble, Patrick J.
Published in Infectious diseases and therapy (01.12.2020)

Get full text

Journal Article

Cover Image

1676. PK, Safety and Tolerability of VABOMERE® (meropenem-vaborbactam) in Infants, Children and Adolescents

by Bokesch, Paula M, Arrieta, Antonio C, Bradley, John S, Hoover, Randall K, McCurdy, Sandra
Published in Open forum infectious diseases (27.11.2023)

Get full text

Journal Article

Cover Image

Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-ß-Lactamase Inhibitor Combinations

by Zhanel, George G, Lawrence, Courtney K, Adam, Heather, Schweizer, Frank, Zelenitsky, Sheryl, Zhanel, Michael, Lagacé-Wiens, Philippe R S, Walkty, Andrew, Denisuik, Andrew, Golden, Alyssa, Gin, Alfred S, Hoban, Daryl J, Lynch, Joseph P, Karlowsky, James A
Published in Drugs (New York, N.Y.) (01.01.2018)

Get full text

Journal Article

Cover Image

Meropenem–Vaborbactam Pharmacokinetics in Subjects with Chronic Renal Impairment, Including Hemodialysis

by Rubino, Christopher M, Griffith, David C, Bhavnani, Sujata M, Loutit, Jeffrey S, Lohse, Brooke, Dudley, Michael N, Ambrose, Paul G
Published in Open forum infectious diseases (01.10.2017)

Get full text

Journal Article

Cover Image

Meropenem-Vaborbactam: Outcomes in Subjects with Renal Impairment in Phase 3 Studies TANGO I and II

by Mathers, Amy, Hope, William, Kaye, Keith S, Loutit, Jeffrey S, Alexander, Elizabeth, Dudley, Michael N, Vazquez, Jose
Published in Open forum infectious diseases (01.10.2017)

Get full text

Journal Article

Cover Image

Meropenem-Vaborbactam vs. Best Available Therapy for Carbapenem-Resistant Enterobacteriaceae Infections in TANGO II: Outcomes in Immunocompromised Patients

by Paterson, David L, Kwak, Eun J, Bhowmick, Tanaya, Alexander, Elizabeth, Loutit, Jeffrey S, Zhang, Shu, Dudley, Michael N, Walsh, Thomas J
Published in Open forum infectious diseases (01.10.2017)

Get full text

Journal Article

Cover Image

Meropenem-Vaborbactam vs. Best AvailableTherapy for Carbapenem-ResistantEnterobacteriaceae Infections in TANGO II: PrimaryOutcomes by Site of Infection

by Wunderink, Richard, Giamarellos-Bourboulis, Evangelos, Rahav, Galia, Mathers, Amy, Bassetti, Matteo, Solomkin, Joseph, Alexander, Elizabeth, Loutit, Jeffrey S, Zhang, Shu, Dudley, Michael N, Kaye, Keith S
Published in Open forum infectious diseases (01.10.2017)

Get full text

Journal Article

Cover Image

Meropenem-Vaborbactam vs. Piperacillin-Tazobactam in TANGO I (a Phase 3 Randomized, Double-blind Trial): Outcomes by Baseline MIC in Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis

by Walsh, Thomas J, Bhowmick, Tanaya, Darouiche, Rabih, Zaitsev, Valerii, Giamarellos-Bourboulis, Evangelos, Shorr, Andrew F, Fedosiuk, Elena, File, Thomas M, Loutit, Jeffrey S, Lomovskaya, Olga, Dudley, Michael N, Perlin, David
Published in Open forum infectious diseases (01.10.2017)

Get full text

Journal Article

Cover Image

Clinical Outcomes of Serious Infections due to Carbapenem-Resistant Enterobacteriaceae (CRE) in TANGO II, a Phase 3, Randomized, Multi-National, Open-Label Trial of Meropenem-Vaborbactam (M-V) Vs. Best Available Therapy (BAT)

by Kaye, Keith S, Vazquez, Jose, Mathers, Amy, Daikos, George, Alexander, Elizabeth, Loutit, Jeffrey S, Zhang, Shu, Dudley, Michael N, Cornely, Oliver
Published in Open forum infectious diseases (01.10.2017)

Get full text

Journal Article

Cover Image

Clinical Outcomes of Patient Subgroups in the TANGO II Study

by Bhowmick, Tanaya
Published in Infectious diseases and therapy (01.03.2021)

Get full text

Journal Article

Cover Image

Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase–Producing Klebsiella pneumoniae Infections: A Retrospective, Observational, 2-Center Clinical Study

by Oliva, Alessandra, Campogiani, Laura, Savelloni, Giulia, Vitale, Pietro, Lodi, Alessandra, Sacco, Frederica, Imeneo, Alessandra, Volpicelli, Lorenzo, Polani, Riccardo, Raponi, Giammarco, Sarmati, Loredana, Venditti, Mario
Published in Open forum infectious diseases (01.07.2023)

Get full text

Journal Article